Prostate cancer, tumor immunity and a renewed sense of optimism in immunotherapy Nicolò RigamontiMatteo Bellone Review 14 February 2012 Pages: 453 - 468
The aggressiveness of murine lymphomas selected in vivo by growth rate correlates with galectin-1 expression and response to cyclophosphamide Mariano F. Zacarías FluckLeonardo HessO. Graciela Scharovsky Original article 27 September 2011 Pages: 469 - 480
Immunological effects of Taxol and Adryamicin in breast cancer patients C. PanisL. G. T. LemosR. Cecchini Original article 30 September 2011 Pages: 481 - 488
Recombinant human CD137L for cancer immunotherapy: effects of different fusions and linkers on its activity Shuzhen WangJunfang LvYijun Chen Original article 04 October 2011 Pages: 489 - 495
A Th1 cytokine–enriched microenvironment enhances tumor killing by activated T cells armed with bispecific antibodies and inhibits the development of myeloid-derived suppressor cells Archana ThakurDana SchalkLawrence G. Lum Original article 05 October 2011 Pages: 497 - 509
The small molecule TGF-β signaling inhibitor SM16 synergizes with agonistic OX40 antibody to suppress established mammary tumors and reduce spontaneous metastasis Kendra GarrisonTobias HahnEmmanuel T. Akporiaye Original article 05 October 2011 Pages: 511 - 521
Tipifarnib-mediated suppression of T-bet-dependent signaling pathways Fanqi BaiAlejandro V. VillagraPearlie Epling-Burnette Original article 09 October 2011 Pages: 523 - 533
Mycobacteria activate γδ T-cell anti-tumour responses via cytokines from type 1 myeloid dendritic cells: a mechanism of action for cancer immunotherapy Daniel W. FowlerJohn CopierMark D. Bodman-Smith Original article Open access 15 October 2011 Pages: 535 - 547
Intratumoral interleukin-2/agonist CD40 antibody drives CD4+-independent resolution of treated-tumors and CD4+-dependent systemic and memory responses Connie JackamanDelia J. Nelson Original article 15 October 2011 Pages: 549 - 560
CpG or IFN-α are more potent adjuvants than GM-CSF to promote anti-tumor immunity following idiotype vaccine in multiple myeloma Sungyoul HongJianfei QianQing Yi Original article 15 October 2011 Pages: 561 - 571
Therapeutic effect of intratumoral administration of DCs with conditional expression of combination of different cytokines Chun HuangRupal RamakrishnanDmitry I. Gabrilovich Short communication 06 January 2012 Pages: 573 - 579
The entirely carbohydrate immunogen Tn-PS A1 induces a cancer cell selective immune response and cytokine IL-17 Ravindra A. De SilvaDananjaya K. AppulagePeter R. Andreana Short Communication 02 February 2012 Pages: 581 - 585
First International Meeting of the Thematic Centre for Immune Modulatory Therapies for Autoimmunity and Cancer (IMTAC) 13–14 June 2011, Ljusterö, Sweden Aniruddha ChoudhuryPetter HöglundAnders Österborg Meeting report 15 January 2012 Pages: 587 - 591